🎺🎺 Our popular UBC TI #Deprescribing webinar series returns January 28! 😍 REGISTER NOW: ti.ubc.ca/deprescribin... Case: Deprescribing multiple psychotropic medications Presenter: Cara Mills, Clinical Pharmacist #MedEd #CME #antidepressants #mentalhealth #BetterPrescribing

💡 Large retrospective study finds approximately 1 in 20 nursing home residents who start #gabapentinoids go on to receive a loop diuretic within 3 months. The study highlights the prevalence of an often overlooked prescribing cascade! Read the full article here: buff.ly/5u5O3qh

Un nouvelle étude de notre partenaire Mieux-Dormir.ca révèle qu'au N-B, près de 1/4 (22%) des aînés prend des sédatifs pour dormir: presque 3x la moyenne nationale (8%). Visionnez le reportage du Téléjournal Acadie de @info.radio-canada.ca pour en savoir plus: tinyurl.com/msw9uhbn

ICYMI - #Deprescribing webinar recording! 😍 When making decisions about 🛑 #statins, consider: ✅pt values, preferences ✅health status ✅current evidence Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres... #MedEd #ptsafety #medsafety

We are delighted to share that our feasibility study results are now published in Research in Social and Administrative Pharmacy! 🎉 📄 Read here: doi.org/10.1016/j.sa... A huge thank you to everyone who contributed to this work! #Research #Pharmacy #Deprescribing #HealthcareInnovation

🚨 ICYMI: UBC TI Therapeutics Letter 156: Antidepressant withdrawal syndrome – Update 👉 ti.ubc.ca/letter156 Antidepressants can be helpful for some people; but starting or stopping requires care Knowing about types of possible withdrawal problems helps prescribers guide patients in 🛑 more safely

🩺 A brief (100 seconds!) video intro to TI Portraits: youtu.be/ZCoDcz98LgA ⏱️Quick+easy sign-up 🔄Personal #PrescribingPortraits 📄Compare w/ peers 🏆CME credits Sign up & receive confidential, personalized #prescribing recommendations: ti.ubc.ca/portrait #MedEd

This project was a part of our multi-year DIAL Study to investigate, "Deintensifying Diabetes Management for Older Adults Living in Long-Term Care". Learn more about the DIAL study here: buff.ly/x6o51mW Find deprescribing.org's antihyperglycemic #deprescribing resources here: buff.ly/TaViSam

ICYMI: 3 pearls for Peripheral edema from the TI's Dr. Jessica Otte @drotte.medsky.social #DrugEvidence25 #edema #MedEd

ICYMI: #Deprescribing webinar 👇🏽 Antidepressant withdrawal effects & how to safely stop them🛑 youtube.com/watch?v=LRr0... ✅ Maudsley approach to deprescribing #antidepressants ✅ Hyperbolic tapering ✅ Distinguishing withdrawal effects #MedEd #MedSafety

Shared decision-making is key to successful deprescribing interventions that reflect the goals and priorities of patients and their care partners. Find our newly updated deprescribing.org shared-decision making tools here: lnkd.in/gQAX4fGi

🚨 ICYMI: UBC TI Therapeutics Letter 156: Antidepressant withdrawal syndrome – Update 👉 ti.ubc.ca/letter156 Antidepressants can be helpful for some people; but starting or stopping requires care Knowing about types of possible withdrawal problems helps prescribers guide patients in 🛑 more safely

ICYMI - #Deprescribing webinar recording! 😍 When making decisions about 🛑 #statins, consider: ✅pt values, preferences ✅health status ✅current evidence Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres... #MedEd #ptsafety #medsafety

Join us February 10, 2026 in Ottawa or online for the launch our 2026 Health & Media Tracking Survey results with the Empire Club of Canada. We’ll examine the growing influence of health misinformation and the actions needed to respond. Register here 👇 bit.ly/4oQmQsi #HMTS2026

Gabapentinoid #deprescribing guidelines are being currently developed by Danijela Gnjidic's team at @sydney.edu.au. Find their project listed on our Deprescribing Guidelines Repository (DEPOT) here: buff.ly/OCTfpeI

Dr. Allyson Harrison on #ADHD: How many professionals apply ALL five DSM-5 criteria before diagnosising ADHD? 🤔 #DrugEvidence25 #MedEd #CME

TI Annual Course ti.ubc.ca/annual-cours... Speaking now: Dr. Guillaume Grenet "Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes" 👎 LOW evidence for primary CVD prevention #DrugEvidence25 #CME #MedEd #T2DM #diabetes #GLP1

🚨Our TI Annual Course returns for day 2! ti.ubc.ca/annual-cours... Speaking now: Dr. David Juurlink (keynote) "Treating pain is harder than it looks" #DrugEvidence25 #pain #opioids #chronicpain #NSAIDs

🚨Now presenting: the TI's Dr. Aaron Tejani Therapeutics Initiative Prescribing Portraits for BC clinicians To sign up for Prescribing Portraits: www.ti.ubc.ca/portrait/ #DrugEvidence25 #MedEd #BetterPrescribing

🚨Speaking now: Dr. Colin Dormuth (TI Co-Director) Overlooked challenges in comparing treatment benefits & harms in randomized trials #DrugEvidence25

🚨Dr. Iliana Lega on menopausal hormone therapy #DrugEvidence25 #menopause #MedEd #CME #MHT

Dr. Otte's 3 pearls for Peripheral edema #DrugEvidence25 #edema #MedEd

ICYMI: TI #BestEvidence webinar recording Using your TI Portrait & mysleepwell.ca for optimal #insomnia management 🎤 Speakers: Dr. Aaron Tejani + Dr. David Gardner 👩🏽‍💻 Video: www.youtube.com/watch?v=jC9g... #PrescribingPortraits #MedEd #deprescribing #BetterPrescribing

2/ Objectives: ✅ Understand how racemic drugs & single-enantiomer versions compare in real clinical outcomes by reviewing RCT evidence ✅ Critically evaluate manufacturer claims about superiority of single-enantiomer 💊 in light of study quality, risk of bias, pt-important outcomes #DrugEvidence25

🧵 Register now for our Annual Course, offered virtually this year: ti.ubc.ca/annual-cours... 1/ Featuring expert speakers including Dr. Aaron Tejani @amtejani.bsky.social "One of these things is a lot like the other. Is the use of enantiomers versus racemic drugs rational in BC?" #DrugEvidence25

🆕 TI #BestEvidence webinar recording Using your TI Portrait & mysleepwell.ca for optimal #insomnia management 🎤 Speakers: Dr. Aaron Tejani + Dr. David Gardner 👩🏽‍💻 Video: www.ti.ubc.ca/insomnia-por... #PrescribingPortraits #MedEd #deprescribing #BetterPrescribing

🚨 TI ANNUAL COURSE - SPECIAL PROMOTION FOR STUDENTS! 🚨 Our annual course is now almost full. For a limited time we're offering a number of complimentary (FREE) registrations to medical, pharmacy & nurse practitioner students/residents in BC. Details + registration: ti.ubc.ca/annual-cours...

🚨Check out our latest TI Blog update! 🚨 www.ti.ubc.ca/2025/11/13/t... ✅ Therapeutics Letter 159 compares citalopram to escitalopram 💊⚖️ ✅ Our 2025 TI annual course is nearly SOLD OUT! 👩‍💻 ✅ Dr. Allyson Harrison on ADHD & other disability diagnoses #BetterPrescribing #BetterHealth #MedEd

As it turns out, escitalopram is just a marketing parachute for citalopram. Oops! /undoes escitalopram Rxs that could have just been cheaper and equalky safe/effectivr citalopram… 😬👀

Escitalopram frente a citalopram: marketing, no evidencia. Misma efectividad y seguridad, doble precio. Citalopram de primera elección. En tratamientos ya iniciados, considerar la posibilidad de cambiar las prescripciones de escitalopram por citalopram a dosis equipotente de 2:1.

Find helpful resources for #PPI #Deprescribing such as deprescribing guidelines, algorithms, patient resources, and more from deprescribing.org here: deprescribing.org/resources/de...

The C-SENIoR Trial, recently published in the Drugs & Aging journal by @springernature.com demonstrates the outcomes of a multifaceted, multidisciplinary intervention on Proton Pump Inhibitor (PPI) #deprescribing! Read the full article here: link.springer.com/article/10.1...

🚨Bringing Best Evidence to Clinicians, our TI annual course, is now FULLY SUBSCRIBED! New registrants will be added to the wait list and offered a spot if someone cancels: ti.ubc.ca/annual-cours... #DrugEvidence25 #BetterPrescribing #BetterHealth #MedEd

🚨UBC TI Therapeutics Letter 159 Escitalopram vs citalopram www.ti.ubc.ca/letter159 ✅ Citalopram best choice for most new prescriptions ✅ Citalopram costs less + works just as well #BetterPrescribing #prescribing #MedEd #antidepressants

ICYMI: TI #BestEvidence webinar recording 🚨 Highlights from TI Portrait Featuring the TI's Dr. Aaron Tejani 👉 youtube.com/watch?v=-5V9... Sign up for TI Portrait here: ti.ubc.ca/portrait #prescribing #MedEd #BetterPrescribing

ICYMI - #Deprescribing webinar recording! 😍 When making decisions about 🛑 #statins, consider: ✅pt values, preferences ✅health status ✅current evidence Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres... #MedEd #ptsafety #medsafety

🚨ICYMI - TI #BestEvidence webinar Addressing medications that are ineffective & potentially harmful for patients with alcohol & other substance use disorders 💊🍻🚬 ti.ubc.ca/harms-aud-sud/ Speaker: Dr. Evan Wood #polypharmacy #alcohol #substanceusedisorder

ICYMI: Talking to patients about #Antibiotics Patient handout: When Are Oral Antibiotics the Right Choice? ti.ubc.ca/antibiotics-... 👉🏼See also our TI Letter 155: ti.ubc.ca/Letter155 #PatientEducation #MedEd #prescribing

Looking for guidance on how to stop PPIs safely? Find our evidence-based PPI deprescribing guideline, algorithm, infographic, and patient pamphlet to help guide appropriate deprescribing of PPIs here: buff.ly/tHiUEmo Also check out Choosing Wisely Canada's "Bye-Bye, PPI" toolkit: buff.ly/Vch4OB3

ICYMI - TI #BestEvidence Webinar recording: Oral vs IV Antibiotics ti.ubc.ca/antibiotics-... See also: TI Therapeutics Letter on #antibiotics: ✅ ti.ubc.ca/letter155 Patient handout: When are oral antibiotics the right choice? ✅ ti.ubc.ca/antibiotics-... #MedEd #CME #BetterPrescribing

#BetterPrescribing -> Better Health ❤️💪 Physician? Nurse Practitioner? Pharmacist? Researcher? 👩🏾‍⚕️👨‍⚕️ ✅Never miss another UBC Therapeutics Initiative webinar, workshop, or publication ✅SUBSCRIBE to our Letters & events: bit.ly/31oXMAK #independent #MedEd #deprescribing

The 3rd keynote speaker at the #PrescQIPP2025 Annual Event and Awards is leading academic psychiatrist Dr Mark Horowitz. Dr Horowitz will discuss Deprescribing Antidepressants, including patient perspectives and practical guidance. Register at prescqipp.info/community-re...

ICYMI - #Deprescribing webinar recording! 😍 When making decisions about 🛑 #statins, consider: ✅pt values, preferences ✅health status ✅current evidence Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres... #MedEd #ptsafety #medsafety

🚨ICYMI - #BestEvidence webinar recording 😍 Safe & sound: Polypharmacy & rational primary care ti.ubc.ca/drugevidence24 Dr. Dee Mangin describes vital aspects of primary care in maximizing therapeutic benefit + provides examples/areas of challenge for rational treatment #DrugEvidence24 #MedEd

ICYMI: What happens when invisible/abandoned clinical trials are re-examined? 🔍🤔 Watch Dr. Juan Erviti in our TI #BestEvidence webinar: ti.ubc.ca/RIAT #MedEd #medsafety #SegPac #ResearchMethods

🚨 TI #BestEvidence webinar recording 😍 The TI's Dr. Anshula Ambasta discusses "Thyroid testing for primary hypothyroidism" 👉 www.youtube.com/watch?v=8-QN... See also: TI Therapeutics Letter: ti.ubc.ca/letter154 TI Prescribing Portrait: ti.ubc.ca/thyroid-port... #MedEd #diagnosis

ICYMI: UBC TI Therapeutics Letter 157: How to 🛑 antidepressants 👉 ti.ubc.ca/letter157 🐌 Avoid abrupt discontinuation 👀 Monitor patients after dose reductions 👩‍🏫 Patient education + shared decision-making to minimize harms and improve outcomes #deprescribing #MedEd #antidepressants #ptsafety

Toronto-area MDs and pharmacists: Join us for Therapeutics Day 2025 - Relevant topics - Great speakers (but also me) - You will be fed - You will get CE credits Register here: tinyurl.com/mr447y5n